Literature DB >> 1282934

Specific binding of cytotactin to sulfated glycolipids.

K L Crossin1, G M Edelman.   

Abstract

The binding of the glial glycoprotein, cytotactin, to a variety of purified glycolipids was examined. Clear-cut evidence was found for binding of radiolabeled cytotactin to sulfatides purified from bovine brain, but the molecule did not bind to gangliosides or cerebrosides. The sulfatide binding was sensitive to pH and ionic strength and was dependent on the presence of divalent cations. Binding was inhibited by purified unlabeled cytotactin, by polyclonal antibodies to cytotactin, and by several monosaccharides and polysaccharides. It was not inhibited by fibronectin, a chondroitin sulfate proteoglycan, or the HNK-1 monoclonal antibody, all of which are known to bind to cytotactin. These findings raise the possibilities that sulfated glycolipids may function as cellular receptors for cytotactin and that binding by sulfatides may modulate the varied effects of cytotactin on cellular processes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1282934     DOI: 10.1002/jnr.490330416

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  4 in total

Review 1.  A glycosynapse in myelin?

Authors:  Joan M Boggs; Huimin Wang; Wen Gao; Dina N Arvanitis; Yanping Gong; Weixian Min
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

2.  Myelin-associated glycoprotein and myelin galactolipids stabilize developing axo-glial interactions.

Authors:  Jill Marcus; Jeffrey L Dupree; Brian Popko
Journal:  J Cell Biol       Date:  2002-02-04       Impact factor: 10.539

Review 3.  Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.

Authors:  Xiao Li; Zhongguo Sui; Xin Li; Wen Xu; Qie Guo; Jialin Sun; Fanbo Jing
Journal:  Int J Nanomedicine       Date:  2018-05-25

4.  Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma.

Authors:  Xiao Li; Fei Qin; Li Yang; Liqian Mo; Lei Li; Lianbing Hou
Journal:  Int J Nanomedicine       Date:  2014-08-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.